ArticleBMJ open2026
Mapping stakeholders for developing cancer research in Small Island Developing States: a descriptive study from the Eastern Caribbean.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07695116 (Overseas Care and Cancer Survivorship in Small Island Developing States of the Eastern Caribbean), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Overseas Care and Cancer Survivorship in Small Island Developing States of the Eastern Caribbean
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHigh cancer mortality in Small Island Developing States (SIDS) is compounded by the insufficient evidence from local epidemiological studies. Stakeholder engagement is particularly important in SIDS to ultimately drive these studies and cancer control. We aimed to map cancer control stakeholders as part of the development of the CaSIDEC study.
methodsThe Cancer in Small Island Developing States of the Eastern Caribbean (CaSIDEC) study investigates the role of overseas travel on cancer survivorship in the six countries of the Organisation of Eastern Caribbean States (OECS). Stakeholders were identified during the study planning phases through professional networks, snowballing and public directories. Persons interested in research/cancer care or those capable of influencing it were included in the analysis. We assessed power and interest by attributing scores based on publicly available content and previous interactions. Based on scores, stakeholders were categorised into engagement typologies: promoters, latent, advocates or bystanders. Descriptive statistics were computed, and country-specific variations were examined.
resultsOf 159 identified stakeholders, 96 were analysed. The stakeholder subgroups included supporters (36%), policymakers (32%), implementers (18%) and civil society leaders (14%). The overall mean scores for interest and power were low (4.5/10, SD=2.6 and 4.7/10, SD=2.5, respectively). 29% of stakeholders were classified as latent, 28% as bystanders, 23% as advocates and 20% as promoters. Of these promoters, the majority were implementers and policymakers (36% each). Antigua, Saint Vincent and Saint Kitts had more representation from policymakers but less from implementers compared with other islands.
conclusionWe carried out the first analysis in the Caribbean, mapping stakeholders for an epidemiological study. Like other developing countries, interest in developing a large-scale epidemiological study was low among stakeholders. Cancer support groups and implementers were strong advocates for this research. Our findings will help guide efforts to increase the political will needed to generate new knowledge and policy. TRIAL REGISTRATION NUMBER: NCT07695116.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.